Delek US director sells 105,968 shares
Delek US Holdings director Ezra Uzi Yemin reported pre-planned open-market sales of 105,968 shares of Common Stock under a Rule 10b5-1 trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Delek US Holdings director Ezra Uzi Yemin reported pre-planned open-market sales of 105,968 shares of Common Stock under a Rule 10b5-1 trading plan. On April 29, 2026 and May 1, 2026, shares were sold at weighted average prices around $44.86–$47.03.
Part of the stock was held directly and part through Yemin Investments, LP. After these transactions, Yemin continues to hold 210,161 shares directly and 481,941 shares indirectly, according to the filing.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 120 | $47.03 | $6K |
| Sale | Common Stock | 577 | $47.03 | $27K |
| Sale | Common Stock | 1,138 | $44.86 | $51K |
| Sale | Common Stock | 7,633 | $46.07 | $352K |
| Sale | Common Stock | 9,367 | $46.91 | $439K |
| Sale | Common Stock | 5,467 | $44.86 | $245K |
| Sale | Common Stock | 36,669 | $46.07 | $1.69M |
| Sale | Common Stock | 44,997 | $46.91 | $2.11M |
Footnotes (5)
- F1. This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- F2. The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $44.40 per share to a high sale price of $45.35 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price.
- F3. The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $45.40 per share to a high sale price of $46.39 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price.
- F4. The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $46.40 per share to a high sale price of $47.24 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price.
- F5. The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $47.02 per share to a high sale price of $47.065 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price.
Key Figures
Key Terms
Rule 10b5-1 regulatory
weighted average sale price financial
open-market sale financial
Common Stock financial
indirect ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Delek US (DK) director Ezra Uzi Yemin report in this Form 4?
Were the Delek US (DK) insider sales made under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.